U.S. markets open in 5 hours 47 minutes

MannKind Corporation (MNKD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.7500-0.0200 (-0.53%)
At close: 04:00PM EST
3.7993 +0.05 (+1.31%)
After hours: 07:31PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close3.7700
Bid0.0000 x 4000
Ask0.0000 x 3000
Day's Range3.6050 - 3.8201
52 Week Range3.3800 - 5.7500
Avg. Volume2,427,340
Market Cap1.011B
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-0.1200
Earnings DateFeb 21, 2024 - Feb 26, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MNKD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MannKind Corporation
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • Simply Wall St.

    Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years

    It hasn't been the best quarter for MannKind Corporation ( NASDAQ:MNKD ) shareholders, since the share price has fallen...

  • Insider Monkey

    MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript

    MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript November 7, 2023 MannKind Corporation beats earnings expectations. Reported EPS is $0.01, expectations were $-0.02. Operator: Good afternoon and welcome to the MannKind Corporation 2023 Third Quarter Financial Results Earnings Call. As a reminder, this call is being recorded on November 7th, 2023, and will be available […]

  • Motley Fool

    MannKind (MNKD) Q3 2023 Earnings Call Transcript

    As a reminder, this call is being recorded on November 7, 2023, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until November 21, 2023. Joining us today from MannKind are Chief Executive Officer Michael Castagna and Chief Financial Officer Steven Binder.